Neurofeedback for Suicide Prevention

N/A

Recruiting

Led By Philip R Szeszko, PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

U.S. military veteran between 18-65 years old

Clinically stabilized on psychotropic medications

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in total score from pre-treatment to post-treatment (2 weeks).

Awards & highlights

No Placebo-Only Group

Summary

This trial uses real-time brain imaging to help Veterans at high risk of suicide learn to manage their suicidal thoughts. By showing them their brain activity, they can practice ways to change it and reduce harmful thinking patterns. The goal is to improve their quality of life and reduce the risk of suicide.

Who is the study for?

This trial is for Veterans experiencing mood disorders, suicidal thoughts or behaviors, and depression. It aims to help them learn strategies to manage their brain activity related to suicide-specific rumination through feedback signals.

What is being tested?

The intervention being tested is Real Time fMRI Neurofeedback, which provides participants with live feedback on brain activation associated with repetitive focus on suicidal thoughts, in hopes of teaching them how to alter this activity.

What are the potential side effects?

Since the trial involves non-invasive neurofeedback using fMRI, there are minimal side effects expected. Participants may experience discomfort from lying still during the MRI or anxiety from being in a confined space.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a U.S. military veteran aged between 18-65.

Select...

My mental health condition is stable on current medications.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in total score from pre-treatment to post-treatment (2 weeks).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in total score from pre-treatment to post-treatment (2 weeks).

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in total score from pre-treatment to post-treatment (2 weeks). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability and Feasibility

Secondary study objectives

Suicide Rumination Scale

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Real-time fMRI NeurofeedbackExperimental Treatment1 Intervention

This is a pilot study to collect feasibility and acceptability data regarding the utility of real-time functional magnetic resonance imaging feedback for veterans experiencing suicide-specific rumination. All study participants will receive the intervention.

0 / 2Eligibility criteria met